In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel
SOURCE CITATION: Navarese EP, Khan SU, Kolodziejczak M, et al. Comparative efficacy and safety of oral P2Y 12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials. Circulation. 2020;142:150-60. 32468837.
| Errataetall: |
CommentOn: Circulation. 2020 Jul 14;142(2):150-160. - PMID 32468837 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:173 |
|---|---|
| Enthalten in: |
Annals of internal medicine - 173(2020), 8 vom: 20. Okt., Seite JC44 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nanna, Michael G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
A74586SNO7 |
|---|
| Anmerkungen: |
Date Completed 22.12.2020 Date Revised 18.08.2021 published: Print CommentOn: Circulation. 2020 Jul 14;142(2):150-160. - PMID 32468837 Citation Status MEDLINE |
|---|
| doi: |
10.7326/ACPJ202010200-044 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316446033 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316446033 | ||
| 003 | DE-627 | ||
| 005 | 20231225161111.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7326/ACPJ202010200-044 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1054.xml |
| 035 | |a (DE-627)NLM316446033 | ||
| 035 | |a (NLM)33075264 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nanna, Michael G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.2020 | ||
| 500 | |a Date Revised 18.08.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Circulation. 2020 Jul 14;142(2):150-160. - PMID 32468837 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a SOURCE CITATION: Navarese EP, Khan SU, Kolodziejczak M, et al. Comparative efficacy and safety of oral P2Y 12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials. Circulation. 2020;142:150-60. 32468837 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Purinergic P2Y Receptor Antagonists |2 NLM | |
| 650 | 7 | |a Clopidogrel |2 NLM | |
| 650 | 7 | |a A74586SNO7 |2 NLM | |
| 650 | 7 | |a Prasugrel Hydrochloride |2 NLM | |
| 650 | 7 | |a G89JQ59I13 |2 NLM | |
| 650 | 7 | |a Ticagrelor |2 NLM | |
| 650 | 7 | |a GLH0314RVC |2 NLM | |
| 700 | 1 | |a Granger, Christopher B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of internal medicine |d 1945 |g 173(2020), 8 vom: 20. Okt., Seite JC44 |w (DE-627)NLM000012777 |x 1539-3704 |7 nnns |
| 773 | 1 | 8 | |g volume:173 |g year:2020 |g number:8 |g day:20 |g month:10 |g pages:JC44 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7326/ACPJ202010200-044 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 173 |j 2020 |e 8 |b 20 |c 10 |h JC44 | ||